≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Erosion of teeth

EFO Endpoint Browser PheWeb

K11_EROSION

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • K11_DENTAL_OPER
290470

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K03.2
  • Hospital discharge: ICD-9 — 5213
  • Hospital discharge: ICD-8 — 5213
  • Cause of death: ICD-10 — K03.2
  • Cause of death: ICD-9 — 5213
  • Cause of death: ICD-8 — 5213

2 out of 7 registries used, show all original rules.

605

4. Check minimum number of events

None

605

5. Include endpoints

None

605

6. Filter based on genotype QC (FinnGen only)

605

Control definitions (FinnGen only)

Control exclude
K11_ORAL
Control conditions
K11_DENTAL_OPER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF10

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2821 1282 1527
Only index persons 2663 1237 1426
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.04
Only index persons 0.05 0.05 0.05
Median age at first event (years)
Whole population 38.59 39.55 37.77
Only index persons 40.02 40.27 39.79

-FinnGen-

Key figures

All Female Male
Number of individuals 605 309 296
Unadjusted period prevalence (%) 0.12 0.11 0.13
Median age at first event (years) 44.76 44.02 45.54

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
521
Matched controls
5209
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K03.29
ICD-10 Finland
Erosion of teeth occupational
338.7
264.4
248
14
K03.00
ICD-10 Finland
Approximal wear
+∞
238.4
210
*
K03.28
ICD-10 Finland
Other erosion of teeth
115.4
199.8
209
30
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
+∞
178.7
161
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
26.8
132.2
189
108
K05.30
ICD-10 Finland
Periodontitis complex
+∞
107.1
99
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
7.9
101.6
369
1230
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
65.3
95.1
109
21
SBB10
NOMESCO Finland
Teeth copy
9.1
83.2
201
337
127
Kela drug reimbursment
Transplant complication
85.4
78.0
86
12
SAA03
NOMESCO Finland
Extended examination of mouth
6.7
71.1
441
2348
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
12.1
69.0
134
145
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
5.5
68.6
384
1766
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
25.6
67.0
95
45
SAA04
NOMESCO Finland
Special inverstigation of mouth
11.1
67.0
136
160
K05.31
ICD-10 Finland
Periodontitis pronounced
+∞
63.9
60
*
K03.2
ICD-10 Finland
Erosion of teeth
38.0
61.3
78
24
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
58.5
60.8
71
14
A11CC03
ATC
alfacalcidol; systemic
42.9
59.8
74
20
Z94.0
ICD-10 Finland
Kidney transplant status
92.7
59.5
65
8
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
51.2
59.4
71
16
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
635.9
58.9
57
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
16.3
57.8
96
71
K03.09
ICD-10 Finland
Abrasion of the teeth UNS
+∞
57.4
54
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
61.7
56.2
65
12
L04AA06
ATC
mycophenolic acid; systemic
39.6
52.5
66
19
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.5
52.1
102
108
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
79.6
51.2
57
8
K03.08
ICD-10 Finland
Other wear and tear of the teeth
+∞
49.8
47
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
73.5
47.1
53
8
K03.66
ICD-10 Finland
Tooth plaque
7.8
47.1
117
186
TK800
NOMESCO Finland
Hemodialysis
35.5
46.6
60
19
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.4
46.4
215
719
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
6.2
46.1
138
284
Z49.1
ICD-10 Finland
Extracorporeal dialysis
251.7
45.7
46
*
R4110
NOMESCO Finland
Physiotherapy
4.4
45.3
207
679
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
18.7
42.5
66
40
K05.1
ICD-10 Finland
Chronic gingivitis
+∞
42.3
40
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
4.1
42.1
214
762
H02AB09
ATC
hydrocortisone; systemic
16.1
41.8
69
49
EBA10
NOMESCO Finland
Surgical removal of tooth
6.3
41.0
120
237
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
81.6
40.6
45
6
A12AA04
ATC
calcium carbonate; oral
41.4
39.5
49
13
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
39.4
219
833
K02.0
ICD-10 Finland
Caries limited to enamel
4.3
39.3
178
565
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.2
38.7
180
585
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
38.4
140
356
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
37.1
264
1208
137
Kela drug reimbursment
Uraemia requiring dialysis
43.6
35.9
44
11
K05.18
ICD-10 Finland
Chronic gingivitis
+∞
35.8
34
*
K03.0
ICD-10 Finland
Excessive attrition of teeth
+∞
35.8
34
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
15.7
35.6
59
42
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
72.0
35.5
40
6
K03.24
ICD-10 Finland
Erosion of teeth NOS
84.3
35.3
39
5
TPH04
NOMESCO Finland
Cathetrisation of vein
4.0
35.3
170
562
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
27.7
35.2
48
19
K05.32
ICD-10 Finland
Periodontitis NOS
+∞
33.7
32
*
B05DA
ATC
Isotonic solutions
58.4
32.7
38
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
32.7
122
313
B03XA02
ATC
darbepoetin alfa; parenteral
43.2
32.6
40
10
XF400
NOMESCO Finland
ECG with 12 standard connections
4.3
32.6
139
407
ZX120
NOMESCO Finland
Intravenous
5.6
31.8
101
216
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
31.7
179
666
Z49.2
ICD-10 Finland
Other dialysis
55.1
30.7
36
7
Z49.0
ICD-10 Finland
Preparatory care for dialysis
113.4
30.0
32
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
3.1
29.9
219
980
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
6.0
29.9
88
171
L04AD01
ATC
ciclosporin; systemic
16.4
29.7
48
32
EBB10
NOMESCO Finland
Insertion of dental implant
60.4
29.5
34
6
K06.18
ICD-10 Finland
Another gingival hyperplasia
+∞
29.5
28
*
SPC01
NOMESCO Finland
Fixed dental crown
30.0
29.3
39
14
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
19.9
29.3
44
24
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
15.4
29.0
48
34
K07.60
ICD-10 Finland
Snapping jaw
8.9
28.8
63
79
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
21.6
28.8
42
21
SBA10
NOMESCO Finland
Measurement of excretion of saliva
38.5
28.7
36
10
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
29.1
28.4
38
14
EBA15
NOMESCO Finland
Extraction of large number of teeth
12.2
28.3
52
47
WX002
NOMESCO Finland
Sedation and analgesia
3.8
28.2
137
445
C03CA01
ATC
furosemide; systemic
4.1
28.1
125
375
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
45.3
28.1
34
8
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
27.2
27.9
38
15
L04AA01
ATC
[U] ciclosporin; systemic
24.7
27.8
39
17
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
24.7
27.8
39
17
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
50.1
27.8
33
7
R4190
NOMESCO Finland
Nutritional therapy
6.4
27.8
77
138
H02AB04
ATC
methylprednisolone; systemic
4.5
27.7
109
291
N18.0
ICD-10 Finland
End-stage renal disease
56.6
27.5
32
6
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.6
27.3
85
176
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
9.4
27.1
57
67
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
102.2
26.9
29
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
13.9
26.7
46
36
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.8
26.3
47
40
L04AX01
ATC
azathioprine; systemic
6.6
25.7
69
118
TPH07
NOMESCO Finland
Cathetrisation of artery
5.1
25.7
86
193
SPA02
NOMESCO Finland
Preparation for dental prosthetics
15.6
25.7
42
29
TK820
NOMESCO Finland
Peritoneal dialysis
52.9
25.5
30
6
K03.1
ICD-10 Finland
Abrasion of teeth
+∞
25.2
24
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.4
24.9
79
167
WX110
NOMESCO Finland
Local anesthesy
3.4
24.6
454
3459
SPB10
NOMESCO Finland
Production of temporary crone to tooth
36.5
24.5
31
9
B05DB
ATC
Hypertonic solutions
39.7
24.2
30
8
B03XA01
ATC
erythropoietin; parenteral
91.1
23.9
26
*
A06AD11
ATC
lactulose; oral
4.8
23.8
85
204
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.9
23.4
60
96
N18.8
ICD-10 Finland
Other chronic renal failure
17.5
23.1
36
22
K11.70
ICD-10 Finland
Hypoptyalism
87.4
22.9
25
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
36.9
22.3
28
8
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
10.8
22.3
43
43
5AB14
NOMESCO Finland
NA
+∞
22.0
21
*
K01.0
ICD-10 Finland
Embedded teeth
+∞
22.0
21
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.9
22.0
99
296
SPB06
NOMESCO Finland
Production of temporary clinic-made tooth- or implant-retained crown or bridge unit
83.8
21.9
24
*
F45.8
ICD-10 Finland
Other somatoform disorders
4.5
21.8
83
212
Z94.4
ICD-10 Finland
Liver transplant status
229.2
21.8
22
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
8.8
21.7
47
58
J01FF01
ATC
clindamycin; systemic
2.8
21.1
163
719
J01MA12
ATC
levofloxacin; systemic
3.4
21.0
114
395
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.7
20.8
415
3076
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
31.5
20.8
27
9
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
31.5
20.8
27
9
ZXA10
NOMESCO Finland
Bilateral
3.2
20.7
126
475
602
Kela drug reimbursment
Children's severe malnutrition
19.3
20.7
31
17
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
19.3
20.7
31
17
K07.23
ICD-10 Finland
Deep bite
5.2
20.6
66
140
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.8
20.5
72
169
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
18.2
20.3
31
18
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
20.1
124
471
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
60.0
20.1
23
*
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
+∞
19.9
19
*
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
+∞
19.9
19
*
EB1WA
NOMESCO Finland
NA
+∞
19.9
19
*
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
76.6
19.8
22
*
WW500
NOMESCO Finland
Blood transfusion
8.3
19.7
44
57
SBA00
NOMESCO Finland
Microbiological examinations
10.2
19.7
39
41
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.4
19.7
53
91
ZXA00
NOMESCO Finland
Right side
2.9
19.6
145
619
EBA00
NOMESCO Finland
Extraction of tooth
2.4
19.6
234
1313
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
48.0
19.3
23
5
3AC01
NOMESCO Finland
NA
23.6
19.3
27
12
R50.9
ICD-10 Finland
Fever, unspecified
3.1
19.2
118
445
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
19.1
125
493
K03.19
ICD-10 Finland
Abrasion of the teeth UNS
+∞
18.9
18
*
K03.01
ICD-10 Finland
Occlusal abrasion
+∞
18.9
18
*
K03.11
ICD-10 Finland
Abrasion dentifrice of teeth
+∞
18.9
18
*
RD210
NOMESCO Finland
NA
7.5
18.9
45
65
SXC03
NOMESCO Finland
Other oral or dental procedure
40.0
18.7
23
6
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
103.8
18.7
20
*
V03AE01
ATC
polystyrene sulfonate; oral
31.4
18.5
24
8
E87.6
ICD-10 Finland
Hypokalaemia
11.7
18.5
34
31
A02BC02
ATC
pantoprazole; systemic
2.3
18.2
307
2012
Z99.2
ICD-10 Finland
Dependence on renal dialysis
+∞
17.8
17
*
WW200
NOMESCO Finland
Immunization
8.1
17.7
40
53
C08CA01
ATC
amlodipine; oral
2.7
17.5
146
662
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.2
17.4
69
182
N05BA04
ATC
oxazepam; oral
2.7
17.3
136
599
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
3.3
17.3
96
336
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
18.2
17.1
26
15
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
26.6
17.0
23
9
EBB15
NOMESCO Finland
Insertion of dental implant abutment
65.6
16.8
19
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
16.8
70
194
K02.1
ICD-10 Finland
Caries of dentine
2.5
16.7
421
3275
J01MA02
ATC
ciprofloxacin; systemic
2.4
16.7
189
1011
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
5.0
16.5
54
117
WX892
NOMESCO Finland
Monitored bed care
4.3
16.5
64
166
N03AX16
ATC
pregabalin; oral
2.7
16.3
130
574
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
16.2
94
338
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.2
15.9
33
38
WX402
NOMESCO Finland
General anaesthesia
2.8
15.8
116
486
K01.17
ICD-10 Finland
Retained molar with obstruction in the lower jaw
+∞
15.7
15
*
BE00A
NOMESCO Finland
NA
+∞
15.7
15
*
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
14.3
15.7
26
19
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
15.6
126
560
V03AG01
ATC
sodium cellulose phosphate; systemic
164.7
15.6
16
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
12.9
15.5
27
22
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.6
15.5
74
230
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
39.4
15.5
19
5
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.5
15.3
36
51
XF602
NOMESCO Finland
Bloodpressure monitoring
13.0
15.0
26
21
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.1
15.0
60
160
SXC05
NOMESCO Finland
Other oral or dental procedure
3.1
14.9
87
313
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
58.4
14.9
17
*
N02AA05
ATC
oxycodone; systemic
3.6
14.8
69
210
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
+∞
14.6
14
*
K03.23
ICD-10 Finland
Erosion of teeth due to: drugs and medicaments
+∞
14.6
14
*
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
+∞
14.6
14
*
N06AB04
ATC
citalopram; systemic
2.6
14.6
120
535
A41.9
ICD-10 Finland
Sepsis, unspecified
8.2
14.6
32
41
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
13.1
14.5
25
20
205
Kela drug reimbursment
Chronic hypertension
2.7
14.5
109
462
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.7
14.4
66
198
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.5
14.4
129
604
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.0
14.1
89
338
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
9.2
13.6
28
32
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
77.2
13.6
15
*
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
77.2
13.6
15
*
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
+∞
13.6
13
*
SFA40
NOMESCO Finland
Replacement of krone of tooth
2.3
13.6
143
725
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
35.1
13.6
17
5
K07.24
ICD-10 Finland
Open bite
13.3
13.5
23
18
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
13.5
59
170
J05AB11
ATC
valaciclovir; oral
3.2
13.5
75
260
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.0
13.5
346
2559
GD1LA
NOMESCO Finland
GD
26.6
13.4
18
7
ZXA05
NOMESCO Finland
Left side
2.5
13.3
122
575
TK810
NOMESCO Finland
Hemofiltration
41.2
13.2
16
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.7
13.1
58
169
A07AA02
ATC
nystatin; oral
5.8
13.1
37
68
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.8
13.1
92
372
D64.9
ICD-10 Finland
Anaemia, unspecified
4.1
13.1
51
133
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
29.2
13.0
17
6
N05CF01
ATC
zopiclone; oral
2.3
13.0
143
735
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
23.2
13.0
18
8
XW000
NOMESCO Finland
Bone marrow biopsy
6.1
12.9
35
61
N06AX21
ATC
duloxetine; oral
3.2
12.8
72
252
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
12.8
172
973
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
71.7
12.6
14
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
12.6
98
419
M79.1
ICD-10 Finland
Myalgia
3.0
12.6
77
286
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.6
12.6
44
103
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
+∞
12.5
12
*
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
+∞
12.5
12
*
K03.20
ICD-10 Finland
Erosion of teeth idiopathic
+∞
12.5
12
*
K05.08
ICD-10 Finland
Another acute gingivitis
+∞
12.5
12
*
K05.22
ICD-10 Finland
Acute pericoronitis
+∞
12.5
12
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
133.1
12.5
13
*
ECA50
NOMESCO Finland
Parodontal operation
133.1
12.5
13
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.2
12.4
38
77
K02.9
ICD-10 Finland
Dental caries, unspecified
12.0
12.4
22
19
K08.3
ICD-10 Finland
Retained dental root
3.9
12.4
51
140
SCE00
NOMESCO Finland
Fissure closure of tooth
3.6
12.3
56
167
UJF30
NOMESCO Finland
Ileoscopy through colon
3.3
12.2
64
213
Z01.9
ICD-10 Finland
Special examination, unspecified
4.4
12.1
44
107
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
12.1
195
1184
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
21.9
12.1
17
8
SFA00
NOMESCO Finland
Small filling
2.5
11.9
105
482
N05BA01
ATC
diazepam; systemic, rectal
2.9
11.9
75
283
K65.0
ICD-10 Finland
Acute peritonitis
16.9
11.7
18
11
KAC00
NOMESCO Finland
Nephrectomy
30.8
11.7
15
5
C09AA02
ATC
enalapril; systemic
2.8
11.7
81
323
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
11.5
11.6
21
19
C07AA05
ATC
propranolol; systemic
2.4
11.6
112
539
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
11.5
92
399
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.8
11.5
38
84
K05.3
ICD-10 Finland
Chronic periodontitis
+∞
11.5
11
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
+∞
11.5
11
*
Z94.1
ICD-10 Finland
Heart transplant status
122.6
11.5
12
*
SAA02
NOMESCO Finland
Basic examination of mouth
0.4
11.4
437
4861
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
12.2
11.4
20
17
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
8.6
11.4
24
29
JN4BD
NOMESCO Finland
Extensive body CT
3.3
11.4
59
195
WX882
NOMESCO Finland
High dependency care
4.7
11.4
38
85
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
35.9
11.3
14
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.5
11.3
54
168
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.2
11.3
59
197
C02AC05
ATC
moxonidine; oral
6.1
11.2
30
52
N06AX16
ATC
venlafaxine; oral
2.6
11.1
90
394
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
11.5
11.1
20
18
J05AB01
ATC
aciclovir; systemic
2.3
11.1
111
542
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
6.5
11.1
28
45
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
7.1
11.0
26
38
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.1
11.0
43
113
A46
ICD-10 Finland
Erysipelas
3.0
11.0
67
248
UJF32
NOMESCO Finland
Coloscopy
2.2
10.9
126
656
C08CA02
ATC
felodipine; oral
4.3
10.9
40
99
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.9
10.8
254
1754
UKC02
NOMESCO Finland
Cystoscopy
2.9
10.8
69
262
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
28.7
10.8
14
5
196
Kela drug reimbursment
Paricalcitol and cinacalcet
28.7
10.8
14
5
TAB00
NOMESCO Finland
Lumbar puncture
4.6
10.7
37
86
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.0
10.7
62
222
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.1
10.7
41
106
V03AE03
ATC
lanthanum carbonate; oral
61.3
10.7
12
*
SCA03
NOMESCO Finland
Preventive oral health care, extensive
3.4
10.7
51
159
SDA02
NOMESCO Finland
Parodonthologic therapy
1.9
10.6
227
1513
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
11.6
10.6
19
17
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.8
10.6
26
40
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
6.4
10.6
27
44
N02AX02
ATC
tramadol; systemic, rectal
2.0
10.6
187
1162
R06.0
ICD-10 Finland
Dyspnoea
2.2
10.5
114
579
BC00A
NOMESCO Finland
NA
112.2
10.5
11
*
4AA09
NOMESCO Finland
NA
112.2
10.5
11
*
K05.39
ICD-10 Finland
Periodontitis UNS
+∞
10.4
10
*
K05.38
ICD-10 Finland
Other chronic periodontitis
+∞
10.4
10
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
16.5
10.4
16
10
N06AB03
ATC
fluoxetine; oral
2.7
10.3
74
302
RS220
NOMESCO Finland
NA
7.7
10.3
23
31
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
2.5
10.1
87
393
K00.00
ICD-10 Finland
Hypodontia
8.7
10.1
21
25
J01DB01
ATC
cefalexin; oral
2.0
10.1
420
3500
SPAT1255
SPAT
Intravenous administration of medicine
3.7
10.1
44
127
F50.9
ICD-10 Finland
Eating disorder, unspecified
10.3
10.1
19
19
A01AB09
ATC
miconazole; local oral
3.2
10.1
53
178
RS221
NOMESCO Finland
NA
7.9
10.0
22
29
N17.9
ICD-10 Finland
Acute renal failure, unspecified
7.9
10.0
22
29
R11
ICD-10 Finland
Nausea and vomiting
3.0
10.0
57
202
N03AE01
ATC
clonazepam; systemic
4.1
9.9
38
98
SAA01
NOMESCO Finland
Simple examination of mouth
2.1
9.9
442
3771
SFB40
NOMESCO Finland
Filling of four surfaces reproduced outside mouth
17.1
9.9
15
9
P01AB01
ATC
metronidazole; oral, rectal
1.9
9.9
185
1165
M04AA01
ATC
allopurinol; systemic
3.2
9.9
53
180
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
9.9
55
190
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
20.5
9.8
14
7
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.8
9.8
64
247
A28
ICPC
Limited function/disability NOS
3.0
9.8
56
199
Z01.7
ICD-10 Finland
Laboratory examination
2.9
9.7
61
230
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
3.6
9.7
43
126
WX199
NOMESCO Finland
Other local analgesia
8.1
9.7
21
27
ECA55
NOMESCO Finland
Complicated parodontal operation
56.1
9.7
11
*
XX3ZW
NOMESCO Finland
NA
56.1
9.7
11
*
SPC05
NOMESCO Finland
Fixed dental crown, demanding
56.1
9.7
11
*
WX290
NOMESCO Finland
Other blockade of nerve
1.8
9.7
292
2159
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.6
9.6
27
50
N05CD07
ATC
temazepam; oral
3.2
9.6
51
173
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.8
9.6
31
68
C07AB02
ATC
metoprolol; systemic
2.5
9.6
76
330
H02AB07
ATC
prednisone; oral
2.7
9.5
67
271
A02BC01
ATC
omeprazole; systemic
2.1
9.5
129
718
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.8
9.5
62
239
A04AA01
ATC
ondansetron; systemic, rectal
3.5
9.5
43
129
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.8
9.5
258
1842
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
101.8
9.4
10
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
101.8
9.4
10
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
101.8
9.4
10
*
ZX197
NOMESCO Finland
NA
+∞
9.4
9
*
K03.18
ICD-10 Finland
Other abrasion of the teeth
+∞
9.4
9
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
+∞
9.4
9
*
N06AX11
ATC
mirtazapine; oral
1.9
9.4
153
917
K02.8
ICD-10 Finland
Other dental caries
5.4
9.4
27
52
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
10.9
9.3
17
16
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
9.2
93
454
XCK10
NOMESCO Finland
Photography of fundus of eye
3.2
9.2
49
166
N05BA12
ATC
alprazolam; oral
2.9
9.2
56
206
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
9.1
54
197
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
37.4
9.0
11
*
SBA20
NOMESCO Finland
Measurement of buffering capacity of saliva
37.4
9.0
11
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.7
9.0
22
34
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
9.0
44
140
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.5
9.0
42
129
K04.7
ICD-10 Finland
Periapical abscess without sinus
3.6
9.0
39
113
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.5
9.0
31
73
ZX121
NOMESCO Finland
Central venous catheter
24.5
8.9
12
5
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.6
8.9
30
69
A01AB04
ATC
amphotericin B; local oral
5.5
8.9
25
47
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
8.9
63
257
R51.80
ICD-10 Finland
Headache
2.2
8.8
97
493
RS222
NOMESCO Finland
NA
9.7
8.8
17
18
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.2
8.8
32
79
A02BC05
ATC
esomeprazole; systemic
1.8
8.8
181
1171
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
8.8
134
777
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.4
8.8
42
132
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
4.8
8.7
28
61
K00.09
ICD-10 Finland
Lack of teeth due to lack of dental development UNS
14.3
8.7
14
10
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.9
8.7
169
1073
K07.13
ICD-10 Finland
Retrognaty, mandibular
6.3
8.7
22
36
XPX08
NOMESCO Finland
Intraoperative flow measurement
50.9
8.7
10
*
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.7
8.6
61
247
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
8.6
99
510
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.2
8.6
89
439
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
4.1
8.6
32
81
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.6
8.6
38
112
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
9.2
8.6
17
19
SPF41
NOMESCO Finland
Repair of dental crown, bridge or implant structure, standard
10.3
8.6
16
16
R55
ICD-10 Finland
Syncope and collapse
2.9
8.5
53
198
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
8.5
40
124
SFB30
NOMESCO Finland
Filling of tree or more surfaces of tooth reproduced outside mouth
20.4
8.5
12
6
V03AE02
ATC
sevelamer; oral
20.4
8.5
12
6
N06AA09
ATC
amitriptyline; systemic
3.2
8.5
44
147
SPC08
NOMESCO Finland
Implant crown
91.5
8.4
9
*
AA1AD
NOMESCO Finland
CT of head and brain
2.1
8.4
96
496
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
8.4
94
482
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
+∞
8.4
8
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
8.4
8
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
8.4
8
*
XX4AW
NOMESCO Finland
NA
11.0
8.3
15
14
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.7
8.3
27
60
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
8.3
53
203
TJD20
NOMESCO Finland
Change of gastrostomy tube
14.8
8.2
13
9
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
8.2
257
1886
C07AB07
ATC
bisoprolol; oral
1.8
8.2
162
1030
EMAK
NOMESCO Finland
NA
4.6
8.2
27
61
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
11.9
8.1
14
12
K11.2
ICD-10 Finland
Sialoadenitis
9.1
8.1
16
18
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
8.0
45
157
A02BA02
ATC
ranitidine; systemic
2.3
8.0
78
374
ZX112
NOMESCO Finland
Subcutaneous
6.8
8.0
19
29
TQW99
NOMESCO Finland
Other minor procedure on skin
4.3
7.9
28
68
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
7.9
51
197
B02.9
ICD-10 Finland
Zoster without complication
4.1
7.9
29
73
C07AG02
ATC
carvedilol; oral
4.6
7.9
26
59
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
7.9
56
227
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
7.8
105
578
M05BA04
ATC
alendronic acid; oral
4.4
7.8
27
64
TQW40
NOMESCO Finland
Remowal of suture of skin
3.2
7.8
39
127
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
7.8
281
2134
B34.9
ICD-10 Finland
Viral infection, unspecified
4.0
7.8
30
79
L03AA02
ATC
filgrastim; parenteral
5.7
7.8
21
38
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
7.7
101
551
SPC25
NOMESCO Finland
Other demanding attachment of crone of tooth
45.7
7.7
9
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
45.7
7.7
9
*
UJD02
NOMESCO Finland
Gastroscopy
3.7
7.7
32
90
C03DA01
ATC
spironolactone; oral
2.9
7.6
45
164
L01BB02
ATC
mercaptopurine; oral
8.2
7.6
16
20
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.2
7.6
16
20
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
7.6
116
671
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.3
7.6
19
31
ZX199
NOMESCO Finland
Other rote
25.4
7.6
10
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
9.0
7.6
15
17
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
2.7
7.6
49
190
XF404
NOMESCO Finland
Ambulatory ECG
2.7
7.5
51
202
N04BC05
ATC
pramipexole; oral
3.5
7.5
34
103
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.8
7.5
30
82
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.6
7.5
55
229
K04.1
ICD-10 Finland
Necrosis of pulp
2.2
7.5
73
352
L04AA05
ATC
[U] tacrolimus; systemic
81.2
7.4
8
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
81.2
7.4
8
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.1
7.4
39
132
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.0
7.4
42
148
F34.1
ICD-10 Finland
Dysthymia
4.3
7.4
26
63
GD1AD
NOMESCO Finland
Thorax CT examination
4.1
7.4
27
68
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.3
7.4
68
319
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
7.0
7.3
17
25
XX9XW
NOMESCO Finland
NA
11.1
7.3
13
12
F50.0
ICD-10 Finland
Anorexia nervosa
11.1
7.3
13
12
K05.0
ICD-10 Finland
Acute gingivitis
+∞
7.3
7
*
SPA05
NOMESCO Finland
Guiding rail
+∞
7.3
7
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
7.3
7
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
6.4
7.3
18
29
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.8
7.3
23
50
WX203
NOMESCO Finland
Infraclavicular plexus blockade
5.9
7.3
19
33
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.9
7.3
19
33
J02AC01
ATC
fluconazole; systemic
1.7
7.3
184
1254
SGC00
NOMESCO Finland
Local medication of root channels of tooth
2.2
7.2
76
378
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
4.9
7.2
22
46
WZA90
NOMESCO Finland
Other doctors statement
1.8
7.2
148
948
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
7.2
228
1656
F50.1
ICD-10 Finland
Atypical anorexia nervosa
20.3
7.2
10
5
N19
ICD-10 Finland
Unspecified kidney failure
6.2
7.1
18
30
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.0
7.1
40
139
N06AX12
ATC
bupropion; oral
2.8
7.1
43
160
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
12.2
7.1
12
10
N05AH04
ATC
quetiapine; oral
2.0
7.1
96
529
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.5
7.1
55
236
H02AB02
ATC
dexamethasone; systemic
2.8
7.1
45
172
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
7.1
7.0
16
23
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
7.1
7.0
16
23
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
7.0
106
610
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.4
7.0
32
98
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
7.0
29
82
ZX114
NOMESCO Finland
Intramuscular
6.5
7.0
17
27
N03AX12
ATC
gabapentin; oral
2.2
7.0
70
342
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.7
6.9
384
3238
TKC20
NOMESCO Finland
Catheterisation of bladder
3.6
6.9
30
88
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
6.9
44
168
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
14.0
6.9
11
8
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
14.0
6.9
11
8
N03AX09
ATC
lamotrigine; oral
3.1
6.9
36
122
R1260
NOMESCO Finland
Evaluation of communicative skills
8.4
6.9
14
17
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.6
6.9
22
49
UJF92
NOMESCO Finland
Capsular endoscopy
4.6
6.9
22
49
K29.3
ICD-10 Finland
Chronic superficial gastritis
5.4
6.8
19
36
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.4
6.8
19
36
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
9.5
6.8
13
14
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
40.6
6.8
8
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
40.6
6.8
8
*
SPF20
NOMESCO Finland
Temporary soling for filling
17.0
6.8
10
6
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
17.0
6.8
10
6
RS210
NOMESCO Finland
NA
17.0
6.8
10
6
R13
ICD-10 Finland
Dysphagia
3.3
6.8
32
101
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.3
6.7
15
21
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
7.3
6.7
15
21
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
6.7
53
229
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
6.7
76
388
R35
ICD-10 Finland
Polyuria
3.2
6.7
33
107
A40.8
ICD-10 Finland
Other streptococcal sepsis
22.8
6.7
9
*
H26.3
ICD-10 Finland
Drug-induced cataract
22.8
6.7
9
*
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
22.8
6.7
9
*
J01CA04
ATC
amoxicillin; systemic
1.8
6.7
439
3872
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.6
6.7
18
33
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
6.0
6.7
17
29
F50.2
ICD-10 Finland
Bulimia nervosa
8.0
6.6
14
18
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.7
6.6
43
167
R4120
NOMESCO Finland
Occupational therapy
2.9
6.6
38
136
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
6.6
108
637
SFC00
NOMESCO Finland
Pillar of fillings material
4.5
6.6
22
51
B07.9
ICD-10 Finland
Verruca simplex
3.4
6.6
30
92
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
6.6
40
150
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
10.2
6.6
12
12
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.5
6.6
29
87
J01EA01
ATC
trimethoprim; systemic
1.9
6.5
96
547
A12BA01
ATC
potassium chloride; oral
6.3
6.5
16
26
C09CA01
ATC
losartan; oral
2.0
6.5
86
468
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.8
6.5
20
43
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
70.7
6.4
7
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
70.7
6.4
7
*
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
70.7
6.4
7
*
SPA48
NOMESCO Finland
Precision impression for denture, demanding
70.7
6.4
7
*
JJ5AT
NOMESCO Finland
NA
70.7
6.4
7
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
70.7
6.4
7
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
70.7
6.4
7
*
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
70.7
6.4
7
*
SPF03
NOMESCO Finland
Impression for dental prosthesis repair, demanding
70.7
6.4
7
*
N06AB10
ATC
escitalopram; oral
1.9
6.4
108
642
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.0
6.4
36
126
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
5.3
6.4
18
35
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
3.9
6.4
24
63
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
5.6
6.3
17
31
K07.22
ICD-10 Finland
Anomalies of dental arch relationship
6.1
6.3
16
27
M79.6
ICD-10 Finland
Pain in limb
1.7
6.3
156
1048
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
11.2
6.3
11
10
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
9.4
6.3
12
13
RS121
NOMESCO Finland
NA
9.4
6.3
12
13
WX110
SPAT
NA
3.2
6.3
31
101
K06.10
ICD-10 Finland
Gingival fibromatosis
+∞
6.3
6
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
+∞
6.3
6
*
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
+∞
6.3
6
*
K01.16
ICD-10 Finland
Retained molar with obstruction in the upper jaw
+∞
6.3
6
*
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
+∞
6.3
6
*
TK823
NOMESCO Finland
Peritoneal permeability analysis
+∞
6.3
6
*
RJ420
NOMESCO Finland
NA
+∞
6.3
6
*
K05
ICD-10 Finland
Gingivitis and periodontal diseases
+∞
6.3
6
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
27.0
6.2
8
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
27.0
6.2
8
*
WX872
NOMESCO Finland
Intensive care
3.4
6.2
28
86
R1250
NOMESCO Finland
Evaluation of functional capability
4.8
6.2
19
41
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
7.8
6.2
13
17
WZC30
NOMESCO Finland
Teaching
2.1
6.1
68
345
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
12.7
6.1
10
8
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.6
6.1
25
71
ECB20
NOMESCO Finland
Oral alveoplasty
8.7
6.1
12
14
XA800
NOMESCO Finland
Neuropsychological investigation
3.1
6.1
31
104
SPAT1262
SPAT
Handing over of treatment supplies
2.0
6.1
78
423
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
10.2
6.1
11
11
XKD06
NOMESCO Finland
Physiologic investigation of micturition
6.1
6.0
15
25
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.7
6.0
19
42
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.0
261
2029

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
118
81
17.86
136.00
15.0
4.6
iu/ml
399.0
1852.6
—
29
9
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
113
106
12.88
107.80
3.0
1.1
u/ml
121.7
111.3
0.44
17
15
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
116
116
12.13
106.03
2.9
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
241
636
5.64
90.60
15.5
3.2
mmol/l
0.8
0.8
3.48
233
609
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
203
489
5.74
83.96
8.1
2.1
%
23.9
23.8
0.04
181
409
(3022948) Iron [Moles/volume] in Serum or Plasma
223
590
5.40
82.67
7.5
2.0
umol/l
13.2
14.9
2.82
214
547
(3003458) Phosphate [Moles/volume] in Serum or Plasma
225
608
5.30
81.18
30.4
4.3
mmol/l
1.2
1.1
1.91
220
565
(3004789) Transferrin [Mass/volume] in Serum or Plasma
209
531
5.49
81.06
7.7
2.0
g/l
2.2
2.5
5.83
204
496
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
119
175
8.22
80.13
24.4
4.0
mg/l
1.7
1.1
6.29
119
169
(40768446) Kidney Pathology biopsy report
48
13
40.02
77.89
2.7
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
170
384
5.77
74.79
35.3
4.9
mmol/l
10.3
7.0
8.72
170
371
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
103
147
8.24
70.84
2.4
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
102
144
8.32
70.81
2.5
1.2
u/ml
330.4
192.0
3.22
73
71
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
59
39
16.65
68.26
1.9
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
284
1039
4.27
67.38
14.8
3.6
%
93.3
92.0
0.37
279
1027
(3024471) HLA-A [Type]
42
13
34.64
65.51
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
42
14
32.16
64.05
1.0
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
366
1642
4.11
64.05
17.0
5.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
162
405
5.10
62.57
29.4
7.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
160
408
4.97
60.16
6.1
2.9
%
1.6
1.6
0.02
150
382
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
60
52
12.70
59.35
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
155
390
5.00
59.16
2.7
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
61
55
12.22
58.84
2.7
2.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
368
1744
3.83
57.44
5.8
2.2
nmol/l
75.4
74.1
0.43
350
1634
(3024561) Albumin [Mass/volume] in Serum or Plasma
358
1675
3.79
56.79
18.1
4.7
g/l
36.0
36.9
2.36
346
1573
(3002032) Base excess in Venous blood by calculation
166
457
4.63
56.45
22.7
3.3
mmol/l
1.3
1.9
1.09
153
364
(3048929) Epstein Barr virus Ab [Presence] in Serum
120
253
5.67
55.97
2.3
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
278
1117
3.75
55.40
19.5
3.2
ph
7.4
7.4
2.68
51
234
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
405
2078
3.87
55.24
16.1
5.6
umol/l
11.4
10.9
0.16
389
1982
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
150
391
4.77
54.50
2.9
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
153
410
4.66
53.63
6.5
4.5
u/l
241.7
236.4
0.21
147
396
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
188
590
4.17
53.44
2.9
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
74
99
8.38
53.33
6.9
3.7
u/ml
0.3
0.4
2.51
39
55
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
116
248
5.55
53.15
2.4
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
59
8
81.32
53.08
6.2
2.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
208
719
3.88
51.29
5.8
2.4
e6/l
0.7
0.7
0.12
129
411
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
197
663
3.92
50.39
6.0
2.6
e6/l
2.1
1.8
0.19
117
353
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
368
1848
3.53
50.29
30.3
5.5
mmol/l
1.2
1.2
0.50
352
1721
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
138
362
4.64
49.41
5.7
2.7
g/l
0.2
0.2
0.00
128
348
(3015377) Calcium [Moles/volume] in Serum or Plasma
292
1286
3.46
49.11
7.1
2.7
mmol/l
2.4
2.4
0.26
267
1179
(3023520) Reticulocytes [#/volume] in Blood
122
291
5.00
49.08
4.1
2.9
e9/l
63.5
68.3
0.74
91
224
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
521
3325
5.08
48.52
19.0
6.5
u/l
90.3
83.9
1.47
506
3149
(3023368) Bacteria identified in Blood by Culture
244
970
3.54
48.19
9.3
4.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
57
64
9.73
47.05
14.5
4.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
407
2233
3.51
46.99
17.3
6.0
%
0.7
0.7
0.02
393
2112
(3006315) Basophils [#/volume] in Blood
433
2469
3.65
46.94
16.8
5.8
e9/l
0.0
0.0
0.11
402
2156
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
159
482
4.12
46.83
12.2
2.7
umol/l
6.7
7.6
0.27
139
419
(3001604) Monocytes [#/volume] in Blood
432
2465
3.63
46.67
16.8
5.8
e9/l
0.6
0.5
3.04
402
2153
(3032080) INR in Blood by Coagulation assay
312
1465
3.33
46.62
14.7
6.4
inr
1.1
1.1
0.16
78
446
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
384
2055
3.38
45.76
31.5
6.0
mmol/l
1.2
1.2
0.81
344
1769
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
74
118
7.01
45.52
2.2
1.9
g/l
1.3
1.5
1.02
68
102
(3042936) Bacteria identified in Isolate by Culture
171
556
3.89
45.49
3.4
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
419
2373
3.49
45.22
16.6
5.7
%
56.8
55.0
2.09
405
2252
(3019069) Monocytes/100 leukocytes in Blood
414
2329
3.46
45.15
17.6
6.3
%
9.0
8.4
5.12
400
2208
(3019198) Lymphocytes [#/volume] in Blood
437
2550
3.57
44.68
16.7
5.8
e9/l
1.9
2.1
1.32
415
2276
(3013650) Neutrophils [#/volume] in Blood by Automated count
460
2772
3.75
44.64
24.2
8.6
e9/l
3.9
3.9
0.11
434
2416
(3006504) Eosinophils/100 leukocytes in Blood
411
2312
3.43
44.62
17.4
6.0
%
2.9
3.0
0.14
397
2177
(40758558) Short blood count panel - Blood
276
1231
3.28
44.48
16.7
6.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
274
1218
3.28
44.39
8.5
2.7
e6/l
0.2
0.3
0.30
224
911
(3013115) Eosinophils [#/volume] in Blood
438
2568
3.56
44.24
18.7
6.2
e9/l
0.2
0.2
0.27
415
2282
(3002030) Lymphocytes/100 leukocytes in Blood
421
2415
3.44
43.97
17.1
5.9
%
28.0
30.3
3.89
407
2282
(36304419) Bacteria [Presence] in Urine
272
1210
3.27
43.91
8.4
2.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
316
1537
3.21
43.74
9.7
3.1
u/l
35.3
30.0
1.15
307
1462
(3014576) Chloride [Moles/volume] in Serum or Plasma
146
437
4.09
43.51
18.7
7.2
mmol/l
103.1
104.5
2.71
141
425
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
86
171
5.70
42.30
8.5
2.8
g/l
3.4
3.4
0.06
81
164
(3026782) Osmolality of Urine
212
828
3.40
42.20
6.3
2.4
mosm/kgh2o
536.3
584.7
2.25
187
691
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
246
1055
3.24
41.87
3.4
2.4
mg/l
2.9
2.7
0.55
220
918
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
46
6
82.95
41.52
4.0
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
131
380
4.12
40.57
5.6
2.4
u/l
41.3
51.6
0.34
118
332
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
59
83
7.77
40.53
1.5
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
59
83
7.77
40.53
1.5
1.1
—
—
—
0
0
(3036489) Thrombin time
91
199
5.21
40.19
7.5
2.4
s
21.9
21.7
0.12
84
175
(3017143) Hepatitis C virus Ab [Presence] in Serum
181
667
3.45
39.19
3.3
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
278
1319
3.05
39.12
8.9
2.7
e6/l
17.9
43.8
2.14
230
1005
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
292
1428
3.02
38.84
2.4
1.8
pmol/l
97.4
96.9
0.06
158
786
(3000494) Fungus identified in Specimen by Culture
153
510
3.68
38.66
2.7
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
306
1545
2.98
38.25
9.6
2.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
127
376
4.01
38.08
4.9
2.6
g/l
9.4
10.2
1.32
122
351
(3007853) Bacteria identified in Skin by Aerobe culture
151
505
3.65
37.90
2.6
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
380
2176
3.01
37.34
6.8
2.6
ug/l
139.2
102.0
1.83
362
2070
(3000850) Epithelial cells [#/volume] in Urine
219
935
3.10
36.75
6.5
2.2
e6/l
4.3
5.8
1.69
194
812
(3013826) Glucose [Moles/volume] in Serum or Plasma
417
2527
3.09
36.68
16.6
4.4
mmol/l
6.3
6.6
1.71
401
2342
(40768797) Stomach Pathology biopsy report
153
530
3.53
36.25
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
273
1333
2.91
35.71
4.9
2.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
233
1045
3.00
35.63
6.7
2.3
umol/l
352.2
4466.6
2.50
213
932
(3021960) Folate [Moles/volume] in Serum or Plasma
195
792
3.16
35.51
2.0
1.4
nmol/l
20.8
21.1
0.10
172
712
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
54
81
7.22
34.96
1.2
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
104
284
4.21
34.67
2.2
1.5
g/l
1.1
1.2
0.46
97
266
(3019309) Folate [Moles/volume] in Red Blood Cells
156
563
3.39
34.48
1.8
1.6
nmol/l
1319.2
1216.2
0.57
130
458
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
231
1048
2.95
34.37
4.7
2.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
30
20
15.73
34.16
4.7
4.6
umol/l
23.2
27.8
1.37
30
20
(3036481) Cortisol [Moles/volume] in Serum or Plasma
137
458
3.57
34.13
3.9
2.1
nmol/l
303.7
361.3
2.52
130
427
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
42
48
9.33
34.04
2.6
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
299
1568
2.79
33.62
11.0
3.1
e6/l
27.7
67.5
1.70
236
1085
(3014148) Varicella zoster virus Ab [Titer] in Serum
49
69
7.64
33.53
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
58
99
6.37
33.21
2.6
1.7
—
—
—
0
0
(4035726)
109
323
3.90
32.35
1.8
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
264
1323
2.77
32.08
5.5
2.3
u/l
56.9
55.2
0.28
246
1243
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
37
39
10.04
31.80
2.8
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
27
17
16.58
31.61
7.3
3.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
241
1161
2.79
31.52
2.0
1.6
mmol/l
1.4
1.4
0.55
216
1010
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
29
0
+∞
30.47
5.4
0.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
51
84
6.54
30.19
6.6
2.4
umol/l
35.4
31.6
0.59
46
72
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
56
102
5.95
29.99
2.5
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
41
54
8.07
29.65
3.0
2.5
e9/l
1.4
1.4
0.05
30
29
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
25
16
16.26
28.98
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
46
71
6.93
28.94
2.0
1.9
—
—
—
0
0
(44806118)
38
47
8.56
28.91
2.1
1.4
—
—
—
0
0
(44790049)
38
47
8.56
28.91
2.1
1.4
—
—
—
0
0
(44790047)
38
47
8.56
28.91
2.1
1.4
—
—
—
0
0
(44790048)
38
47
8.56
28.91
2.1
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
36
42
9.05
28.66
3.3
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
68
154
4.85
28.57
7.6
3.6
g/l
0.4
0.2
1.51
52
69
(3009508) Creatinine [Moles/volume] in Urine
254
1326
2.58
27.46
6.7
3.2
mmol/l
6.6
8.4
8.68
229
1168
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
26
0
+∞
27.29
8.8
0.0
mmol/l
4.3
—
—
26
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
25
18
14.44
27.22
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
31
32
10.16
26.98
6.7
2.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
120
424
3.28
26.95
2.4
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
40
8.95
26.88
3.4
1.9
%
12.2
10.9
0.20
26
21
(3021589) Normoblasts [#/volume] in Blood
362
2249
2.52
26.66
22.9
7.8
e9/l
0.0
0.0
0.60
298
1818
(46235355) HIV 1 and 2 tests - Meaningful Use set
230
1161
2.58
26.49
3.1
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
147
590
2.97
26.47
4.0
2.6
mmol/l
2.4
2.4
0.56
124
524
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
49
89
5.90
26.27
1.9
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
205
992
2.61
25.63
5.7
3.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
169
744
2.76
25.51
4.8
3.3
ng/l
485.9
424.7
0.07
130
496
(3026008) Bacteria identified in Urine by Culture
205
995
2.60
25.44
4.5
2.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
155
658
2.82
25.03
1.6
1.4
titre
584.0
437.1
0.48
30
125
(3031040) Bacteria [#/volume] in Urine by Automated count
425
2891
2.58
25.03
8.7
3.5
e6/l
168.2
1288.5
—
9
33
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
201
977
2.58
24.77
4.7
1.8
mg/l
1.7
1.2
0.70
158
722
(3000060) B lymphocytes [#/volume] in Blood
24
19
13.11
24.72
3.3
1.5
e6/l
162.4
375.0
—
17
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
68
173
4.30
24.63
2.8
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
112
400
3.21
24.57
3.6
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
446
3126
2.62
24.28
9.4
3.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
91
5.52
23.53
4.0
2.3
g/l
7.3
7.1
0.15
36
71
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
91
5.52
23.53
4.0
2.3
g/l
3.5
3.7
0.56
36
67
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
91
5.52
23.53
4.0
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
193
4.03
23.52
2.1
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
84
5.71
23.42
4.2
2.4
g/l
9.7
10.2
0.31
38
72
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
70
6.21
23.37
2.1
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
476
3473
2.74
23.32
7.8
3.6
mm/h
12.8
9.3
5.62
452
3272
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
68
6.23
22.89
2.7
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
86
5.57
22.83
4.2
2.4
g/l
3.2
2.9
0.68
36
68
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
30
37
8.48
22.81
2.7
3.1
e6/l
839.4
707.9
—
7
15
(3004119) Hemoglobin [Mass/volume] in Venous blood
74
212
3.84
22.76
16.7
3.3
g/l
113.6
130.8
7.09
74
205
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
191
943
2.50
22.44
3.2
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
217
1146
2.39
21.88
3.0
2.1
u/l
294.0
181.3
0.45
208
1086
(40768804) Tissue Pathology biopsy report
283
1687
2.27
21.35
2.4
1.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
60
155
4.19
21.25
2.1
1.5
g/l
1.1
1.2
0.85
60
146
(3007566) Smooth muscle Ab [Titer] in Serum
55
135
4.38
20.81
1.8
1.4
titre
44.0
92.0
—
5
15
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
64
6.09
20.80
1.6
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
33
51
6.79
20.66
3.4
2.0
mmol/l
67.5
65.2
0.07
28
45
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
330
2118
2.23
20.50
6.5
3.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
30
43
7.29
20.10
2.2
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
177
884
2.42
19.95
4.3
3.0
ng/l
2106.9
698.9
1.90
159
734
(3052851) Hemolysis interference index of Serum or Plasma
49
114
4.59
19.82
5.6
2.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
17
11
15.87
19.42
2.8
3.0
ug/l
109.9
98.2
0.10
17
11
(3011648) Oxygen content in Venous blood
26
33
8.19
19.28
16.5
3.3
%
10.9
11.4
0.24
26
33
(3003396) Base excess in Arterial blood by calculation
101
392
2.89
18.91
18.5
8.3
mmol/l
0.9
1.2
0.27
85
315
(1616796) Gas panel - Central venous blood
43
94
4.85
18.74
11.0
3.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
209
1149
2.25
18.64
2.1
1.4
g/l
2.2
2.3
0.03
138
690
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
48
117
4.37
18.30
3.5
2.4
ug/l
304.5
414.6
0.25
42
108
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
49
6.39
17.81
2.3
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
22
25
9.09
17.76
3.0
4.1
%
36.5
33.7
—
10
6
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
53
6.11
17.61
1.8
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
88
334
2.91
17.09
3.5
2.1
ml/min/173m2
62.1
72.7
1.07
32
103
(3026389) Candida sp identified in Specimen by Organism specific culture
25
36
7.20
16.65
1.5
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
61
5.48
16.24
1.4
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
333
2275
2.03
16.11
6.8
3.0
estimate
0.0
0.0
0.50
60
405
(3021601) Nitrite [Presence] in Urine by Test strip
331
2257
2.03
16.09
9.5
4.1
estimate
0.0
0.0
0.50
63
425
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
65
214
3.28
16.08
21.6
10.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
60
190
3.40
15.79
3.5
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
35
75
4.89
15.60
14.2
2.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
63
208
3.26
15.51
2.2
1.7
u/l
5.5
7.5
1.16
49
159
(3012501) Base excess in Blood by calculation
39
92
4.46
15.48
15.9
3.9
mmol/l
2.3
2.6
0.15
25
47
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
44
114
4.08
15.48
2.7
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
140
701
2.30
15.23
2.5
1.6
%
1.7
1.4
2.41
121
624
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
51
5.71
14.90
1.7
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
409
3055
2.05
14.86
4.9
3.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
326
2251
1.97
14.85
6.8
3.1
estimate
0.0
0.0
0.50
61
409
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
16
15
10.93
14.70
1.0
1.1
%
106.9
81.1
1.96
16
15
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
16
15
10.93
14.70
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
23
36
6.60
14.19
2.8
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
521
4311
2.50
14.09
29.1
9.1
ml/min/173m2
85.1
90.1
3.07
429
3502
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
573
4983
3.83
14.01
39.2
10.3
mg/l
21.4
22.0
0.16
495
3731
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
439
3400
2.06
13.95
9.3
3.0
u/l
55.4
45.0
1.67
420
3261
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
44
123
3.78
13.93
1.3
1.2
u/ml
67.1
34.1
—
8
5
(3009343) pH of Capillary blood
90
385
2.57
13.77
15.7
3.8
ph
7.4
7.4
0.20
19
28
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
41
110
3.93
13.75
1.3
1.2
u/ml
3.6
4.0
—
9
16
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
41
110
3.93
13.75
1.3
1.2
u/ml
1.3
2.5
—
7
9
(40767503) Oxygen content in Capillary blood by calculation
31
67
4.82
13.67
5.3
2.6
%
17.6
17.1
0.29
22
33
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
38
97
4.11
13.63
3.6
3.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
379
2.55
13.26
15.9
3.8
mmol/l
1.4
1.5
0.15
66
287
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
61
4.94
13.20
2.2
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
42
119
3.72
13.05
2.1
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
81
338
2.61
13.01
2.0
1.5
iu/l
10.8
25.0
7.29
65
285
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
28
58
5.01
12.97
1.6
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
49
156
3.33
12.77
1.4
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
17
7
24.92
12.52
2.9
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
40
113
3.72
12.48
1.6
1.3
ug/g
240.9
304.2
0.97
21
66
(3012516) Albumin [Mass/volume] in Urine
187
1119
1.97
12.46
6.5
3.3
mg/l
1043.9
159.8
1.07
134
743
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
32
77
4.33
12.39
1.3
1.2
u/ml
5.6
4.8
0.07
17
39
(3002256) Pathology report gross observation
102
485
2.33
12.34
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
22
7.92
12.34
2.0
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
520
4373
2.35
12.28
50.0
12.5
%
13.8
13.4
8.32
515
4287
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
32
78
4.28
12.19
5.2
3.3
—
1.2
—
0
6
(3048689) Calprotectin [Mass/mass] in Stool
135
723
2.12
12.19
3.2
2.7
ug/g
164.7
101.4
0.74
110
582
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
115
3.65
12.17
5.2
4.1
%
52.8
56.0
0.66
40
115
(3030905) Polymorphonuclear cells [#/volume] in Blood
39
112
3.65
11.88
4.4
3.7
e9/l
3.5
4.0
0.62
39
112
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
522
4419
2.32
11.75
5.9
4.3
mu/l
1.9
2.1
0.23
502
4169
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
44
5.39
11.62
1.7
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
59
223
2.82
11.46
5.5
4.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
50
4.96
11.04
2.3
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
461
3761
1.95
10.95
4.8
3.8
pmol/l
14.2
14.5
1.77
440
3518
(3005322) IgE [Units/volume] in Serum or Plasma
85
397
2.33
10.66
1.8
1.3
u/ml
195.7
265.8
0.28
78
363
(3023199) Leukocytes [#/volume] in Pleural fluid
16
23
7.12
10.62
1.7
1.3
e6/l
723.7
3469.1
—
10
16
(3028433) Virus identified in Specimen by Culture
15
20
7.67
10.60
1.2
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
586
5307
4.32
10.58
26.5
8.4
u/l
29.3
27.6
1.18
578
5185
(3025315) Body weight
10
0
+∞
10.44
6.4
0.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
27
6.45
10.32
3.0
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
45
155
3.06
10.31
2.2
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
205
1332
1.82
10.25
1.5
1.5
u/ml
2.1
2.6
0.14
44
327
(3017446) Testosterone [Moles/volume] in Serum or Plasma
88
424
2.26
10.25
2.8
2.5
nmol/l
11.8
12.3
0.24
77
379
(40768806) Pleura Pathology biopsy report
16
24
6.82
10.22
1.2
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
21
7.30
10.17
1.7
1.2
e6/l
15064.1
26104.0
—
8
10
(3002179) Metamyelocytes/100 leukocytes in Blood
72
319
2.43
10.15
5.5
4.3
%
0.3
0.5
0.93
22
84
(3020682) Albumin/Creatinine [Ratio] in Urine
184
1161
1.84
10.10
7.0
4.0
mg/mmol
40.4
7.6
3.27
132
758
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
185
2.86
10.10
2.7
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
72
322
2.40
9.94
16.7
3.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
493
4163
2.00
9.92
8.4
4.6
mmol/mol
37.7
38.8
1.61
476
3977
(3006184) Hemoglobin [Mass/volume] in Capillary blood
32
91
3.66
9.90
3.8
2.1
g/l
134.0
134.3
0.02
23
64
(3000492) Spirometry study
99
508
2.13
9.85
1.8
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
53
207
2.71
9.67
1.4
1.5
—
—
—
0
0
(4062490)
24
57
4.34
9.46
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
26
66
4.07
9.41
5.0
2.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
23
6.66
9.39
1.1
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
12
14
8.72
9.37
1.8
1.1
u/l
362.3
430.9
0.17
12
14
(3017181) Myelocytes/100 leukocytes in Blood
75
351
2.30
9.34
6.0
4.2
%
0.5
1.1
2.33
30
108
(3025159) Blasts/100 leukocytes in Blood
70
318
2.36
9.33
6.0
4.2
%
0.0
0.2
1.16
27
86
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
59
4.19
9.06
1.3
1.3
g/l
0.4
0.4
0.04
17
39
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
59
4.19
9.06
1.3
1.3
g/l
2.4
3.0
0.70
18
39
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
59
4.19
9.06
1.3
1.3
g/l
5.6
7.1
1.35
18
40
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
12
5
24.42
8.94
2.5
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
22
51
4.44
8.93
3.3
3.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
29
83
3.62
8.90
1.3
1.2
u/ml
1.3
1.7
0.40
15
35
(3023410) Appearance of Cerebral spinal fluid
20
43
4.78
8.88
5.0
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
74
3.77
8.81
8.1
2.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
49
4.40
8.46
3.8
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
30
5.45
8.24
1.9
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
67
316
2.26
8.18
3.8
3.7
ug/l
4.2
8.0
0.77
59
242
(3024980) IgG subclass 4 [Mass/volume] in Serum
29
89
3.37
8.03
1.3
1.7
g/l
0.5
0.7
0.68
21
66
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
80
3.49
7.89
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
169
1108
1.73
7.86
9.3
4.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
36
128
2.93
7.83
3.4
3.2
u/ml
114.2
7697.2
0.50
31
111
(3022145) Colonoscopy Study observation
85
449
2.04
7.78
1.4
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
21
6.30
7.74
1.8
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
21
6.30
7.74
1.8
1.7
u/l
13.4
0.9
—
8
9
(40761511) CBC panel - Blood by Automated count
578
5316
2.96
7.63
29.2
9.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
18
6.78
7.63
1.7
1.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
43
171
2.63
7.59
14.0
3.3
mmol/l
24.9
25.0
0.09
43
164
(21494890) Protein electrophoresis panel - 24 hour Urine
15
29
5.28
7.48
4.0
2.2
—
—
—
0
0
(4306422)
27
83
3.36
7.47
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
33
4.95
7.44
4.4
2.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
68
336
2.15
7.41
6.3
4.3
%
0.0
0.2
3.54
29
100
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
79
3.39
7.32
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
48
206
2.44
7.25
1.9
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
200
1400
1.64
7.16
4.0
2.8
ng/l
30.0
71.8
0.70
127
787
(3016018) Differential panel - Cerebral spinal fluid
19
47
4.14
7.13
3.5
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
23
5.75
7.09
11.4
7.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
86
3.24
7.07
1.1
1.1
—
—
—
0
0
(4010399)
62
301
2.18
7.06
1.9
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
8
13.97
6.91
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
8
13.97
6.91
2.5
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
36
4.54
6.74
1.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
36
4.54
6.74
1.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
36
4.54
6.74
1.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
21
5.81
6.61
1.6
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
37
4.41
6.52
11.1
4.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
55
3.73
6.52
2.0
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
509
4517
1.80
6.51
5.6
3.7
mmol/l
5.9
5.8
1.06
481
4256
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
7
14.50
6.41
1.5
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
35
138
2.63
6.31
1.9
2.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
56
275
2.14
6.20
2.3
2.2
ug/l
5.8
6.0
0.06
44
248
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
58
3.53
6.05
3.6
1.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
27
4.90
6.00
1.4
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
27
4.90
6.00
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
79
3.12
5.98
3.9
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
28
101
2.86
5.97
4.0
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
87
508
1.83
5.89
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
36
4.25
5.85
1.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
36
4.25
5.85
1.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
36
4.25
5.85
1.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
11
20
5.58
5.82
2.4
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
9
11.27
5.81
5.0
3.2
—
—
—
0
0
(4268621)
18
50
3.68
5.80
2.6
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
57
290
2.07
5.77
1.6
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
24
5.08
5.76
3.3
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
28
4.72
5.76
1.1
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
81
3.04
5.75
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
536
4879
1.86
5.66
48.8
11.2
%
38.5
40.5
9.17
447
3925
(3022217) INR in Platelet poor plasma by Coagulation assay
68
372
1.93
5.63
30.0
18.9
inr
1.2
1.3
—
7
77
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
21
5.32
5.54
4.4
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
21
5.32
5.54
4.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
21
5.32
5.54
3.5
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
29
4.56
5.53
3.7
1.1
g/l
0.9
0.9
0.09
13
29
(21494755) Public health laboratory ask at order entry panel
33
716
0.43
5.51
1.4
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
120
783
1.66
5.50
1.8
1.6
pmol/l
127778280.1
48256234.0
0.39
108
688
(3008295) Osmolality of Serum or Plasma
18
52
3.54
5.49
1.6
1.5
mosm/kgh2o
283.4
285.3
0.14
13
35
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
37
161
2.38
5.46
1.5
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
598
5762
4.27
5.43
53.5
15.4
e9/l
256.7
256.7
0.00
592
5623
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
34
4.19
5.38
1.6
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
163
2.35
5.32
1.5
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
30
4.41
5.32
1.6
2.6
u/ml
1652.1
832.0
0.76
13
30
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
27
102
2.72
5.31
4.1
1.7
e6/l
1910.2
603.8
0.42
19
82
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
27
102
2.72
5.31
4.1
1.6
e6/l
10.6
38.4
0.42
19
78
(3010813) Leukocytes [#/volume] in Blood
598
5768
4.18
5.28
53.5
15.4
e9/l
6.7
6.6
1.03
591
5617
(3026361) Erythrocytes [#/volume] in Blood
598
5767
4.19
5.28
53.5
15.4
e12/l
4.4
4.6
22.15
592
5621
(42529406) Shigella sp [Presence] in Stool by Culture
37
164
2.34
5.25
1.5
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
44
3.71
5.23
2.1
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
14
35
4.07
5.19
1.3
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
92
2.79
5.16
1.6
1.4
nmol/l
0.2
0.3
0.77
19
69
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
9
10.13
5.04
1.6
1.7
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
9
10.13
5.04
2.1
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
23
4.85
5.03
1.4
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
28
4.35
4.84
1.2
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
28
4.35
4.84
1.3
1.3
—
—
—
0
0
(3020891) Body temperature
32
138
2.39
4.84
13.7
3.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
44
218
2.10
4.80
3.4
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
48
3.40
4.63
1.0
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
27
110
2.52
4.61
1.4
2.5
mg/l
12.1
9.9
0.59
27
105
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
64
367
1.83
4.60
1.2
1.2
iu/ml
57.0
156.3
3.24
27
130
(40768443) Skin Pathology biopsy report
33
148
2.30
4.59
1.3
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
5
14.14
4.58
1.4
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
13
34
3.89
4.55
1.5
1.9
umol/l
2.9
4.3
1.07
13
34
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
21
4.83
4.54
3.7
1.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
21
4.83
4.54
1.7
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
68
401
1.78
4.46
9.5
3.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
26
4.29
4.37
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
524
4815
1.66
4.35
6.4
4.1
mmol/l
2.7
2.9
3.15
504
4585
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
56
314
1.86
4.33
3.7
3.1
pmol/l
4.4
4.6
0.56
50
285
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
6
11.78
4.28
2.0
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
42
214
2.03
4.27
1.3
1.3
miu/ml
167.6
242.5
—
8
107
(1001926) Buprenorphine [Presence] in Urine by Screen method
47
250
1.95
4.25
1.9
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
51
3.20
4.23
1.3
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
16
52
3.13
4.11
1.4
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
42
3.39
4.06
1.6
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
42
3.39
4.06
1.6
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
7
10.10
4.02
6.9
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
7
10.10
4.02
1.1
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
7
10.10
4.02
2.6
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
24
4.22
3.90
1.7
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
11
7.35
3.87
4.5
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
114
797
1.53
3.85
1.4
1.2
iu/ml
23.1
22.1
0.05
33
222
(3013247) Albumin in CSF/Albumin in Serum or Plasma
7
8
8.83
3.78
1.1
1.0
mg/g
10.1
3.0
—
7
8
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
8
8.83
3.78
1.1
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
5
12.10
3.77
4.0
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
517
4778
1.56
3.69
6.1
3.8
mmol/l
4.6
4.7
2.88
498
4578
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
45
3.16
3.67
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
35
3.48
3.63
1.3
1.8
u/ml
0.7
1.9
—
6
13
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
165
2.06
3.56
2.1
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
41
3.22
3.51
3.9
4.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
514
4759
1.53
3.48
5.9
3.7
mmol/l
1.4
1.4
0.76
492
4542
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
153
2.08
3.47
1.6
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
14
5.77
3.35
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
498
4591
1.48
3.34
5.4
3.4
mmol/l
1.4
1.3
1.73
474
4384
(1761868) Lipid panel - Serum or Plasma
149
1909
0.71
3.28
2.8
2.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
138
1035
1.43
3.26
5.7
3.3
kg/l
1.0
1.0
0.10
19
169
(21491868) Cryoglobulin [Mass/volume] in Serum
8
15
5.39
3.20
1.4
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
52
315
1.71
3.15
2.1
1.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
16
5.05
3.06
1.1
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
16
5.05
3.06
1.1
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
29
3.49
3.06
2.1
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
57
2.67
2.98
1.7
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
17
4.75
2.92
3.0
2.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
22
4.14
2.89
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
170
1347
1.36
2.88
1.9
1.7
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
7
13
5.43
2.87
2.4
2.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
9
6.72
2.87
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
180
1441
1.35
2.85
1.6
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
571
0.55
2.83
1.9
1.6
—
—
—
0
0
(4281824)
11
36
3.09
2.82
1.5
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
18
4.49
2.80
3.0
2.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
19
84
2.30
2.80
1.8
1.8
e6/l
9241.1
7668.1
0.16
13
66
(3000764) Benzodiazepines [Presence] in Urine
53
335
1.64
2.76
2.1
1.9
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
6
8.39
2.75
1.2
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
6
8.39
2.75
1.2
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
6
8.39
2.75
1.6
1.8
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
6
10
6.05
2.70
17.8
9.5
umol/l
0.3
0.3
—
6
10
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
141
1.96
2.64
2.0
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
152
1199
1.36
2.63
8.2
3.4
estimate
0.0
0.0
1.08
60
413
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
15
4.71
2.60
1.4
4.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
53
341
1.61
2.59
2.1
1.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
15
62
2.46
2.56
1.3
1.3
u/l
179.3
50.1
0.74
15
55
(3013727) Leukocytes other/100 leukocytes in Blood
6
11
5.50
2.55
3.0
1.8
%
44.8
55.9
—
6
11
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
11
5.50
2.55
1.0
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
49
311
1.63
2.53
8.0
3.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
39
2.85
2.48
2.5
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
39
2.85
2.48
1.2
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
21
3.85
2.47
2.3
1.6
nmol/l
146.1
141.3
—
8
21
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
21
3.85
2.47
1.5
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
12
5.04
2.40
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
52
341
1.57
2.36
2.1
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
98
2.08
2.34
1.6
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
51
335
1.57
2.31
2.1
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
41
2.71
2.29
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
52
345
1.55
2.26
8.2
4.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
29
3.13
2.23
1.3
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
9
5.59
2.21
1.2
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
14
4.32
2.15
6.2
6.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
14
4.32
2.15
2.7
1.4
—
—
—
0
0
(3013512) EKG study
131
1040
1.33
2.15
4.0
3.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
12
49
2.48
2.11
3.4
1.8
mg/l
30.8
25.9
—
5
17
(4027681)
9
31
2.93
2.08
1.1
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
10
5.03
2.07
1.6
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
15
4.03
2.04
6.2
6.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
98
1.97
1.97
1.5
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
51
2.38
1.96
2.1
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
5
11
4.57
1.94
2.4
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
16
3.78
1.94
1.8
1.6
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
10
39
2.59
1.93
1.1
1.0
mg/l
320.0
237.5
—
10
31
(3049717) Cytology report of Urine Cyto stain
21
114
1.87
1.89
2.4
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
207
1772
1.26
1.88
7.1
3.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
46
2.42
1.86
1.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
98
762
1.34
1.85
1.4
1.2
u/ml
6.5
5.1
0.11
22
316
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
17
3.55
1.84
1.2
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
15
73
2.08
1.82
1.2
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
35
2.59
1.80
1.3
2.9
pg
32.6
32.3
—
9
35
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
23
3.07
1.80
2.1
2.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
23
3.07
1.80
4.3
5.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
23
3.07
1.80
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
47
2.37
1.78
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
47
2.37
1.78
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
47
2.37
1.78
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
47
2.37
1.78
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
47
2.37
1.78
1.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
154
1285
1.27
1.73
6.6
2.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
24
2.94
1.72
1.1
1.0
miu/ml
1997.3
1908.2
—
7
24
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
377
0.59
1.68
1.9
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
49
2.27
1.64
2.9
1.8
—
—
—
0
0
(1002224) Polysomnography panel
33
214
1.57
1.63
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
190
1.61
1.63
2.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
111
897
1.29
1.60
2.2
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
20
3.02
1.58
1.2
1.3
—
—
—
0
0
(3036603) Volume of Urine
7
26
2.71
1.58
1.1
1.4
—
1669.2
—
0
6
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
39
265
1.50
1.58
2.9
2.2
u/l
887.6
4355.4
—
8
100
(3023511) Choriogonadotropin [Units/volume] in Urine
21
124
1.72
1.49
1.5
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
66
1.99
1.44
1.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
5
16
3.14
1.44
1.0
1.1
—
1.1
—
0
8
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
146
1236
1.24
1.43
4.3
4.1
ug/l
1.7
1.8
0.28
132
1141
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
197
1.55
1.43
1.3
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
46
2.19
1.40
1.3
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
46
2.19
1.40
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
46
2.19
1.40
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
29
2.43
1.39
1.4
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
23
2.62
1.37
7.8
6.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
82
1.85
1.36
1.3
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
21
332
0.62
1.36
1.4
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
46
335
1.40
1.34
2.0
3.1
e9/l
4.3
4.0
0.31
38
296
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
100
820
1.26
1.30
2.2
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
87
707
1.27
1.22
2.0
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
141
0.49
1.22
1.9
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
19
2.64
1.22
3.4
2.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
19
2.64
1.22
1.6
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
19
2.64
1.22
1.4
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
19
2.64
1.22
1.4
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
359
1.37
1.21
1.6
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
171
0.52
1.19
1.7
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
26
2.32
1.19
1.0
1.5
iu/ml
232.4
303.3
—
6
26
(3013139) Helicobacter pylori Ag [Presence] in Stool
41
300
1.39
1.18
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
72
1.82
1.16
1.4
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
134
1.59
1.15
1.3
2.0
iu/l
11.7
4.7
—
6
55
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
20
2.51
1.15
1.4
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
40
2.01
1.12
1.3
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
66
1.83
1.09
1.3
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
41
1.96
1.09
3.7
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
195
1.46
1.06
1.4
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
22
2.28
1.03
1.4
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.4
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.4
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
53
1.90
1.01
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
36
1.96
0.97
1.1
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
50
1.81
0.97
1.2
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
62
1.79
0.94
1.0
1.1
nmol/l
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
17
109
1.58
0.94
6.3
2.9
mmol/l
4.0
3.9
0.27
17
98
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
37
1.90
0.94
1.3
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
37
1.90
0.94
1.3
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
325
0.70
0.92
1.5
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
206
0.62
0.90
1.8
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
101
0.49
0.90
1.6
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
152
0.59
0.89
1.2
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
30
2.01
0.87
1.7
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
1.3
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
434
4158
1.15
0.86
4.0
3.4
—
—
—
0
0
(4198724)
8
46
1.75
0.82
1.1
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
48
384
1.27
0.81
2.0
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
147
0.61
0.80
1.2
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
124
0.56
0.78
1.7
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
60
496
1.23
0.78
1.9
2.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
196
0.66
0.75
1.4
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
170
0.64
0.71
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
170
0.64
0.71
1.3
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
146
0.61
0.70
1.2
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
169
0.64
0.70
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
169
0.64
0.70
1.3
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
19
135
1.42
0.69
2.6
2.2
pmol/l
197.0
204.2
0.12
19
128
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
59
1.53
0.68
1.2
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
179
0.66
0.67
1.7
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
28
1.79
0.66
1.0
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.4
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.4
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.4
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.4
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
79
1.53
0.63
1.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
80
1.51
0.60
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
80
701
1.16
0.58
2.6
2.6
ug/l
0.8
0.8
0.01
58
426
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
106
1.43
0.58
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
42
354
1.20
0.49
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
90
809
1.13
0.48
1.5
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
84
0.59
0.46
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
51
1.38
0.44
1.6
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
17
0.00
0.40
0.0
3.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
101
0.69
0.40
5.3
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
106
1.33
0.39
1.1
1.1
—
—
—
0
0
(4146454)
5
35
1.43
0.39
2.2
2.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
107
986
1.10
0.39
3.8
3.8
%
25.1
21.9
0.83
32
420
(3020491) Glucose [Moles/volume] in Blood
5
36
1.39
0.38
2.4
1.3
mmol/l
6.4
7.0
—
5
26
(3000330) Specific gravity of Urine by Test strip
14
175
0.80
0.31
6.9
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
52
468
1.12
0.30
7.4
5.3
—
—
—
0
0
(4034850)
17
141
1.21
0.26
5.8
7.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
52
474
1.11
0.25
4.9
3.7
%
31.2
31.3
0.00
42
366
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
179
0.83
0.23
1.1
1.1
u/ml
0.2
6.4
—
6
46
(3045414) Leukocytes [Presence] in Urine
24
209
1.15
0.23
2.5
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
31.8
—
0
10
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
80
1.25
0.20
1.1
1.1
—
—
—
0
0
(44813793)
6
48
1.25
0.20
1.2
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
17
146
1.17
0.19
1.3
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
30
321
0.93
0.10
3.7
2.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
125
0.88
0.10
2.5
3.2
mg/l
31.7
23.1
—
5
77
(4094501)
14
125
1.12
0.10
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
67
1.05
0.08
6.1
2.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
176
1.08
0.07
1.3
1.2
u/ml
0.1
1.8
1.73
12
108
(40768793) Breast Pathology biopsy report
8
76
1.05
0.07
1.1
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
226
1.06
0.06
2.8
1.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
181
1.05
0.03
1.3
1.2
u/ml
5.8
9.5
0.41
14
119
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
177
0.96
0.01
1.4
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
193
1.04
0.01
1.6
1.2
u/ml
0.1
3.1
2.77
13
104
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
127
1.02
0.00
2.2
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
24
236
1.02
0.00
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
121
0.99
0.00
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
121
0.99
0.00
1.3
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
558
1.00
0.00
1.6
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
78
782
1.00
0.00
1.7
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
4.0
—
0.6
—
0
7
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
25.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
85
0.94
0.00
1.6
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
7.8
—
0
9
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
9.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
89
1.01
0.00
1.8
1.2
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
11.7
—
0
5
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
89.4
—
0
5
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.2
—
0.8
—
0
6
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.9
—
44.3
—
0
8
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_EROSION and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_EROSION.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: K11_EROSION – Erosion of teeth

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data